Short interest in Eiger BioPharmaceuticals Inc (OTC:EIGRQ) decreased during the last reporting period, falling from 39.92K to 38.87K. This put 4.56% of the company's publicly available shares short.

Short interest for Eiger BioPharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Eiger BioPharmaceuticals's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 111.95K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.